Rapid translation of a cellular therapeutic: Choosing product & process development solutions for clinical manufacturing readiness

Thursday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET

Sponsor

Rapid translation of a cellular therapeutic: Choosing product & process development solutions for clinical manufacturing readiness

Cell therapies face regulatory and manufacturing challenges long before they are accessible to patients. Even as therapies prove effective and safe, raw material and manufacturing decisions made during early development can either stall progression or rapidly accelerate it. In this webinar, we will explore traditional challenges associated with incorporation of human mesenchymal stem cells (hMSC’s) into cell therapies and the advances being made to improve clinical manufacturing readiness.

How an industrialized supply chain enables rapid translation
The importance of building manufacturing scalability into early process development
How "off-the-shelf" solutions can support regulatory compliance
The value commercial partnerships bring to the translational journey
The MONACO trial illustrates rapid translation for timely treatment of COVID-19 patients